Literature DB >> 31625807

Serum NfL levels should be used to monitor multiple sclerosis evolution - Yes.

David Leppert1, Jens Kuhle1.   

Abstract

Entities:  

Year:  2019        PMID： 31625807     DOI： 10.1177/1352458519872921

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  2 in total

1.  Measuring treatment response to advance precision medicine for multiple sclerosis.

Authors:  Peter A Calabresi; Ludwig Kappos; Gavin Giovannoni; Tatiana Plavina; Irene Koulinska; Michael R Edwards; Bernd Kieseier; Carl de Moor; Elias S Sotirchos; Elizabeth Fisher; Richard A Rudick; Alfred Sandrock
Journal:  Ann Clin Transl Neurol       Date:  2021-10-26       Impact factor: 4.511

2.  Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis.

Authors:  Alice Mariottini; Leonardo Marchi; Chiara Innocenti; Maria Di Cristinzi; Matteo Pasca; Stefano Filippini; Alessandro Barilaro; Claudia Mechi; Arianna Fani; Benedetta Mazzanti; Tiziana Biagioli; Francesca Materozzi; Riccardo Saccardi; Luca Massacesi; Anna Maria Repice
Journal:  Front Neurol       Date:  2022-02-24       Impact factor: 4.003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.